Economic Evaluation of 'Watch and Wait' Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review.
Ishraq MurshedZachary BunjoWarren SeowIshmam MurshedSergei BedrikovetskiMichelle ThomasTarik SammourPublished in: Annals of surgical oncology (2024)
Despite heterogenous methodological design and reporting quality, W&W is likely to be cost effective and cost saving compared with standard care following cCR in LARC. Clinical Trials Registration PROSPERO CRD42024513874.
Keyphrases
- rectal cancer
- locally advanced
- clinical trial
- neoadjuvant chemotherapy
- quality improvement
- phase ii study
- healthcare
- squamous cell carcinoma
- palliative care
- radiation therapy
- regulatory t cells
- dendritic cells
- adverse drug
- randomized controlled trial
- affordable care act
- emergency department
- stem cells
- bone marrow
- electronic health record
- smoking cessation
- cone beam